See more : Lords & Company Worldwide Holdings Inc. (LRDS.CN) Income Statement Analysis – Financial Results
Complete financial analysis of Hengkang Medical Group Co., Ltd. (002219.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hengkang Medical Group Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Ryanair Holdings plc (RYA.L) Income Statement Analysis – Financial Results
- PT Gudang Garam Tbk (GDNGY) Income Statement Analysis – Financial Results
- Clarity Gold Corp. (CLGCF) Income Statement Analysis – Financial Results
- Swire Pacific Limited (SWRBF) Income Statement Analysis – Financial Results
- Check-Cap Ltd. (CHEK) Income Statement Analysis – Financial Results
Hengkang Medical Group Co., Ltd. (002219.SZ)
About Hengkang Medical Group Co., Ltd.
Hengkang Medical Group Co.,Ltd provides medical services, pharmaceuticals, health care, and daily chemical products in China and internationally. It operates approximately 11 hospitals. The company also manufactures pharmaceutical products in the areas of analgesia, cold, cough, gynecology, cardiovascular, digestive, and urinary systems. In addition, it offers Chinese herbal medicines, infusion, and hemostasis products, as well as daily chemical products. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang Medical Group Co.,Ltd in January 2014. Hengkang Medical Group Co.,Ltd. was founded in 2001 and is based in Chengdu, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.59B | 3.15B | 3.02B | 2.81B | 3.68B | 3.84B | 3.40B | 2.18B | 1.18B | 685.66M | 564.73M | 336.96M | 307.24M | 299.33M | 285.12M | 284.97M | 198.23M | 130.10M | 100.23M | 83.97M |
| Cost of Revenue | 2.51B | 2.16B | 2.21B | 2.02B | 2.71B | 3.01B | 2.32B | 1.39B | 628.27M | 274.28M | 174.65M | 126.31M | 107.03M | 108.87M | 119.12M | 129.31M | 101.99M | 79.99M | 59.03M | 45.50M |
| Gross Profit | 1.08B | 992.64M | 807.71M | 790.75M | 972.52M | 826.59M | 1.08B | 783.12M | 553.46M | 411.38M | 390.07M | 210.65M | 200.22M | 190.46M | 166.00M | 155.66M | 96.24M | 50.12M | 41.20M | 38.47M |
| Gross Profit Ratio | 30.07% | 31.49% | 26.78% | 28.18% | 26.40% | 21.53% | 31.82% | 36.00% | 46.83% | 60.00% | 69.07% | 62.51% | 65.17% | 63.63% | 58.22% | 54.62% | 48.55% | 38.52% | 41.10% | 45.81% |
| Research & Development | 27.71M | 237.88K | 444.48K | 296.94K | 1.29M | 8.27M | 447.64K | 1.01M | 7.73M | 8.80M | 9.37M | 8.50M | 9.59M | 8.72M | 0.00 | 2.50M | 2.15M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 457.30M | 86.05M | 114.59M | 80.10M | 215.31M | 134.78M | 95.72M | 41.62M | 23.81M | 13.99M | 8.89M | 8.71M | 6.34M | 8.52M | 30.86M | 11.15M | 13.38M | 12.20M | 10.38M | 12.14M |
| Selling & Marketing | 191.95M | 287.01M | 283.85M | 226.04M | 250.73M | 195.74M | 84.94M | 58.08M | 16.22M | 9.86M | 110.66M | 94.50M | 92.79M | 84.47M | 80.97M | 81.01M | 41.43M | 14.19M | 10.85M | 10.80M |
| SG&A | 649.24M | 373.06M | 398.44M | 306.14M | 466.04M | 330.52M | 180.67M | 99.70M | 40.03M | 23.85M | 119.55M | 103.20M | 99.14M | 92.99M | 111.83M | 92.16M | 54.81M | 26.39M | 21.24M | 22.94M |
| Other Expenses | 368.33M | 318.10M | 322.54M | 258.54M | 384.35M | -37.00M | 7.09M | 32.69M | 72.76M | 32.16M | 3.73M | 11.55M | 9.81M | 6.36M | 3.37M | 7.49M | 2.03M | 2.96M | 2.67M | 50.45K |
| Operating Expenses | 1.04B | 691.40M | 721.42M | 564.98M | 851.68M | 784.42M | 527.17M | 263.47M | 130.85M | 85.42M | 174.43M | 128.99M | 122.84M | 115.05M | 112.96M | 104.59M | 57.07M | 26.82M | 21.81M | 23.32M |
| Cost & Expenses | 3.56B | 2.85B | 2.93B | 2.58B | 3.56B | 3.80B | 2.84B | 1.66B | 759.12M | 359.69M | 349.08M | 255.31M | 229.87M | 223.92M | 232.08M | 233.90M | 159.06M | 106.80M | 80.84M | 68.82M |
| Interest Income | 11.39M | 11.80M | 948.64K | 71.48K | 2.02M | 4.98M | 8.24M | 7.76M | 17.18M | 1.24M | 3.11M | 2.91M | 1.29M | 341.35K | -0.05 | 865.88K | 117.87K | 53.83K | 56.33K | -0.40 |
| Interest Expense | 123.53M | 142.58M | 230.03M | 136.61M | 344.62M | 344.16M | 206.99M | 23.11M | 45.15M | 23.82M | 13.99M | 5.36M | 2.16M | 1.54M | 25.02K | 975.79K | 1.02M | 1.59M | 1.34M | 751.18K |
| Depreciation & Amortization | 217.20M | 185.28M | 176.00M | 180.07M | 143.49M | 244.70M | 205.34M | 105.73M | 69.52M | 40.70M | 40.20M | 28.64M | 21.33M | 16.37M | 6.72M | 5.21M | 4.05M | 4.11M | 4.02M | 3.96M |
| EBITDA | 348.10M | 496.70M | 30.93M | 328.99M | -1.94B | -673.82M | 710.49M | 590.51M | 437.94M | 354.86M | 258.50M | 121.68M | 107.91M | 97.03M | 59.76M | 59.30M | 42.23M | 28.38M | 25.53M | 19.11M |
| EBITDA Ratio | 9.69% | 16.64% | 10.52% | 13.14% | -6.11% | 1.00% | 23.57% | 30.52% | 49.69% | 54.67% | 46.56% | 35.98% | 35.23% | 32.47% | 21.04% | 22.61% | 21.67% | 22.20% | 24.78% | 23.62% |
| Operating Income | 34.64M | 358.04M | 153.95M | 198.10M | 120.84M | -1.30B | 298.72M | 430.02M | 328.06M | 282.12M | 201.02M | 76.48M | 74.36M | 72.75M | 53.23M | 45.78M | 37.84M | 21.26M | 18.80M | 13.68M |
| Operating Income Ratio | 0.96% | 11.36% | 5.10% | 7.06% | 3.28% | -33.79% | 8.79% | 19.77% | 27.76% | 41.15% | 35.60% | 22.70% | 24.20% | 24.31% | 18.67% | 16.06% | 19.09% | 16.34% | 18.76% | 16.29% |
| Total Other Income/Expenses | -24.39M | -1.58M | -516.34M | -129.61M | -33.22M | -37.00M | -157.38M | 31.56M | 72.48M | 8.21M | 3.30M | 8.52M | 8.59M | 4.90M | 2.92M | 2.04M | 2.60M | 1.42M | 1.38M | 50.45K |
| Income Before Tax | 10.26M | 187.48M | -362.39M | 9.99M | -2.44B | -1.33B | 305.81M | 461.58M | 400.54M | 290.34M | 204.32M | 85.00M | 82.95M | 77.65M | 56.16M | 53.11M | 40.44M | 22.68M | 20.18M | 13.73M |
| Income Before Tax Ratio | 0.29% | 5.95% | -12.02% | 0.36% | -66.14% | -34.75% | 9.00% | 21.22% | 33.89% | 42.34% | 36.18% | 25.22% | 27.00% | 25.94% | 19.70% | 18.64% | 20.40% | 17.43% | 20.13% | 16.35% |
| Income Tax Expense | -28.66M | 23.18M | 4.91M | 52.50M | 60.51M | 53.77M | 83.11M | 65.42M | 78.43M | 33.19M | 32.99M | 12.06M | 11.60M | 11.69M | 8.35M | 8.60M | 6.64M | 3.42M | 2.60M | 719.97K |
| Net Income | 30.78M | 156.12M | -367.30M | -42.51M | -2.50B | -1.42B | 202.81M | 403.63M | 323.63M | 257.33M | 169.83M | 73.67M | 71.35M | 65.96M | 47.81M | 44.51M | 33.80M | 19.26M | 17.58M | 13.73M |
| Net Income Ratio | 0.86% | 4.95% | -12.18% | -1.52% | -67.78% | -36.94% | 5.97% | 18.56% | 27.39% | 37.53% | 30.07% | 21.86% | 23.22% | 22.04% | 16.77% | 15.62% | 17.05% | 14.80% | 17.54% | 16.35% |
| EPS | 0.01 | 0.05 | -0.20 | -0.02 | -1.34 | -0.76 | 0.11 | 0.21 | 0.19 | 0.17 | 0.11 | 0.05 | 0.05 | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | 0.03 | 0.03 |
| EPS Diluted | 0.01 | 0.05 | -0.20 | -0.02 | -1.34 | -0.76 | 0.11 | 0.21 | 0.19 | 0.17 | 0.11 | 0.05 | 0.05 | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | 0.03 | 0.03 |
| Weighted Avg Shares Out | 3.38B | 3.26B | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B | 1.75B | 1.54B | 1.53B | 1.50B | 1.50B | 1.50B | 1.50B | 900.47M | 708.50M | 496.88M | 505.38M | 511.67M |
| Weighted Avg Shares Out (Dil) | 3.38B | 3.26B | 1.87B | 1.87B | 1.87B | 1.87B | 1.87B | 1.89B | 1.75B | 1.54B | 1.53B | 1.50B | 1.50B | 1.50B | 1.50B | 900.47M | 708.50M | 496.88M | 505.38M | 511.67M |
Source: https://incomestatements.info
Category: Stock Reports